STOCK TITAN
  1. Home
  2. Sec-filings
  3. XBIT
  4. [ARS] XBiotech Inc SEC Filing

[ARS] XBiotech Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - XBiotech Inc

ARS Filing - XBiotech Inc

This filing is available as a PDF document.

Filing Type: ARS

Company: XBiotech Inc (XBIT)

Acceptance Date: 2025-07-07T17:25:01.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Xbiotech

NASDAQ:XBIT

View XBIT Stock Overview →

XBIT Rankings

#5353 Ranked by Market Cap
N/A Ranked by Dividends

XBIT Latest News

Dec 23, 2024
XBiotech Pauses Rheumatology program
Jun 18, 2024
XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer
Jan 4, 2024
XBiotech to Begin Constructing New R&D Facility on its 48-acre Campus
Nov 14, 2023
Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in Rheumatoid Arthritis
Sep 26, 2023
XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke

XBIT Latest SEC Filings

Mar 13, 2026
[10-K] XBiotech Inc. Files Annual Report
Jan 23, 2026
[SCHEDULE 13G/A] XBiotech Inc. Amended Passive Investment Disclosure
Jan 23, 2026
[SCHEDULE 13G/A] XBiotech Inc. Amended Passive Investment Disclosure
Nov 12, 2025
[10-Q] XBiotech Inc. Quarterly Earnings Report
Nov 12, 2025
[Form 4] XBiotech Inc. Insider Trading Activity

XBIT Stock Data

71.34M
19.32M
Biotechnology
Pharmaceutical Preparations
Link
United States
AUSTIN